Expectations for the Dual Therapy with Vonoprazan and Amoxicillin for the Eradication of H. pylori
Authors:
- Takahisa FurutaTFTakahisa Furuta
- Mihoko YamadeMYMihoko Yamade
- Tomohiro HiguchiTHTomohiro Higuchi
- Satoru TakahashiSTSatoru Takahashi
- Natsuki IshidaNINatsuki Ishida
- Shinya TaniSTShinya Tani
- Satoshi TamuraSTSatoshi Tamura
- Moriya IwaizumiMIMoriya Iwaizumi
- Yasushi HamayaYHYasushi Hamaya
- Satoshi OsawaSOSatoshi Osawa
- Ken SugimotoKSKen Sugimoto
Open Access
- 25 April 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (9) , 3110
Abstract
Vonoprazan (VPZ) inhibits gastric acid secretion more potently than proton pump inhibitors. Recently, attention has been focused on the dual therapy with VPZ and amoxicillin (AMOX) for the eradication of H. pylori. The dual VPZ/AMOX therapy attains the sufficient eradication rate with lowering the risk of adverse events in comparison with the triple therapy and quadruple therapy. Therefore, the dual VPZ/AMOX therapy is considered a useful eradication regimen for H. pylori infection.Keywords
This publication has 56 references indexed in Scilit:
- Dual therapy for third-lineHelicobacter pylorieradication and urea breath test predictionWorld Journal of Gastroenterology, 2012
- Comparative evaluation of synergy of combinations of -lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 2011
- Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori InfectionGastroenterology Clinics of North America, 2010
- Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and ClarithromycinJournal of Clinical Biochemistry and Nutrition, 2010
- Evidence that the Degree and Duration of Acid Suppression are Related to Helicobacter pylori Eradication by Triple TherapyHelicobacter, 2007
- A Prospective, Randomized Study of Quadruple Therapy and High‐Dose Dual Therapy for Treatment of Helicobacter Pylori Resistant to Both Metronidazole and ClarithromycinHelicobacter, 2003
- Comparison of lansoprazole‐based triple and dual therapy for treatment of Helicobacter pylori‐related duodenal ulcer: an Asian multicentre double‐blind randomized placebo controlled studyAlimentary Pharmacology & Therapeutics, 2000
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995
- Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcersGastroenterology, 1995
- An increasing dose of omeprazole combined with amoxicillin improves the cure of Helicobacter pylori infectionGastroenterology, 1995